August 7, 2007 -- PerkinElmer Inc. is pleased to announce the launch of a new introductory configuration for its leading Opera™ High Content Screening (HCS) system. The Opera LX is specifically designed for researchers who need the power of high throughput confocal imaging for their drug discovery and academic research, but in a scalable configuration that can expand as their screening needs increase.

The Opera LX can be custom configured with a laser combination of choice and can be equipped with a number of options, such as an environmental control unit, lenses, UV light source including second camera for parallel image acquisition, liquid handling, plate handling/storage and incubation. All accessory units can be field upgraded thus enabling a user to start with a basic configuration for assay development and small-to-medium throughput campaigns for a variety of applications. The system can be gradually upgraded to the complete Opera configuration, the QEHS, which includes all options and full high throughput live cell screening capacity.

The accompanying Acapella image analysis software with Cellular Assay Library is a powerful, intuitive system that allows for quick training of new users, but also offers full flexibility in algorithm development for the power user.

The Opera LX expands PerkinElmer’s comprehensive drug discovery instrumentation and reagents portfolio, further demonstrating the company’s commitment to providing high-performance live cell imaging technologies to meet the needs and budgets of researchers throughout the life sciences.

For more information about the Opera LX please visit the product page, or contact us.